CSIMarket Company Name, Ticker, Customers, else..
 
IMPACT BIOMEDICAL INC.  (NYSE: IBO)
 
Price: $0.4611 $0.00 0.022%
Day's High: $0.49000000953674316 Week Perf: 4.8 %
Day's Low: $ 0.46 30 Day Perf: 5.03 %
Volume (M): 8,554 52 Wk High: $ 0.49
Volume (M$): $ 0 52 Wk Avg: $0.45
Open: $0.48 52 Wk Low: $0.40



 Market Capitalization (Millions $) 50
 Shares Outstanding (Millions) 108
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Impact Biomedical Inc. focuses on discovering, confirming, and patenting scientific technologies for human healthcare and wellness. The company collaborates with external partners through licensing, co-development, joint ventures, and other relationships. It develops biopharmaceuticals, over-the-counter wellness products, and drug discovery solutions targeting neurological, oncologic, and inflammatory diseases. Impact Biomedical operates through its subsidiaries Global BioLife, Impact BioLife Science, Global BioMedical, and Sweet Sense. The company holds proprietary technologies including Linebacker, Laetose, Functional Fragrance Formulation (3F), and Equivir. It partners with ProPhase Laboratories and Chemia Corporation for development and commercialization worldwide.


   Company Address: 1400 BROADFIELD BLVD. HOUSTON 77084 NV
   Company Phone Number: 585 232 1500   Stock Exchange / Ticker: NYSE IBO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 23.06
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1,420.47
Price to Sales (Expected) -
Price to Book 3.55
PEG (TTM) -

Financial Strength Current
Quick Ratio 0
Working Capital Ratio 0.25
Leverage Ratio (MRQ) 0.43
Total Debt to Equity -
Interest Coverage (TTM) 151
Debt Coverage (TTM) 0.18

Per Share Current
Earnings (TTM) 0.02 $
Revenues (TTM) 0 $
Cash Flow (TTM) -
Cash 0 $
Book Value 0.13 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) 2.46
Asset Turnover Ratio (TTM) 0

Profitability Ratios Current
Gross Margin (MRQ) 66.67 %
Operating Margin (MRQ) -23400 %
Net Margin (MRQ) -23333.33 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 4.1 %
Return On Investment (TTM) 5.68 %
Return On Equity (TTM) 9.56 %
Dividend Yield -
Pay out Ratio (TTM) -



Impact Biomedical's Segments
Biotech Retail Sales    333.33 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.